v3.26.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Consolidated Statements Of Comprehensive Income Abstract      
Net income $ 669,064 $ 193,790 $ 165,732
Amounts that will not be reclassified subsequently to profit or loss:      
Actuarial gain from defined benefit plans 1,450 869 1,993
Gain (loss) from investments in equity instruments measured at fair value through other comprehensive income (473) 6,272 9,996
Share of other comprehensive income (loss) of companies accounted for at equity 101 (3,316) (575)
Adjustments arising from translating financial statements from functional currency to presentation currency 170,212 (5,469) (30,526)
Amounts that will be or that have been reclassified to profit or loss when specific conditions are met:      
Foreign exchange differences on translation of foreign operations from discontinued operations (27,362) (6,210) 18,969
Foreign exchange differences on translation of foreign operations (37,792) (488) 7,240
Total other comprehensive income (loss), net of tax 106,136 (8,342) 7,097
Total Comprehensive income 775,200 185,448 172,829
Total comprehensive income (loss) attributable to non-controlling: interests      
From continued operations 118,499 111,091 90,075
From discontinued operations (4,173) (3,361) 11,379
Total comprehensive income to non-controlling interests 114,326 107,730 101,454
Total comprehensive income attributable to Formula’s shareholders:      
From continued operations 684,063 80,567 63,785
From discontinued operations (23,189) (2,849) 7,590
Total comprehensive income attributable to Formula’s shareholders $ 660,874 $ 77,718 $ 71,375